|Publication number||US2155658 A|
|Publication date||Apr 25, 1939|
|Filing date||Dec 29, 1936|
|Priority date||Jan 8, 1936|
|Publication number||US 2155658 A, US 2155658A, US-A-2155658, US2155658 A, US2155658A|
|Inventors||Willy O Herrmann, Haehnel Wolfram|
|Original Assignee||Chemische Forschungs Gmbh|
|Export Citation||BiBTeX, EndNote, RefMan|
|Referenced by (72), Classifications (15)|
|External Links: USPTO, USPTO Assignment, Espacenet|
Patented Apr. 25, 1939 v UNITED. STATES PATENT OFFICE 2,155,858 suaorcu. AND MEDICAL PREPARATIONS poration of Germany No Drawing. Application December 29,1938, Se-
rial No. 118,088. In Germany January 8.
This invention relates to surgicaland medical preparations and has for its object the production of improved materials for insertion, infusion or injection into the human or animal system for their desirable therapeutic or cosmetic effects, or for use as plastic fillings, joint lubricants and other surgical purposes.
By means of our preparations, for example, medical deposits may be introduced into the tissues as a substitute for the usual method of making frequent injections of dissolved medicines. Similar deposits may be made for the purpose of introducing disinfectants, cosmetics, contrast media and anaesthetics into the body. An important advantage of the invention is that the effect of such deposits, whether for surgical or medical purposes, may be localized in any given regionof the body; for example, by the infusion of a suitable deposit in lumbar anaesthesia, a localized efiect of the anaesthetic contained in the deposit may be obtained.
Plastic fillings made according to our invention may be used wherever cavities are to be filled in the body. For example, lumbar fillings may be introduced after the resection or pathological destruction of parts of the lungs. Likewise, bone fillings may be inserted, paste-like joint greases introduced and the like. Not only does our invention provide improved materials for these and other surgical and medical purposes, but' it furthermore extends the field of application of such materials to a wide variety of purposes not contemplated in the prior art.
Fillings and deposits for some of the purposes mentioned above have been manufactured from parafllne, stearic acids, waxes and the like, but they have met with only indifferent success. One disadvantage of such materials is that they. have an irritating eifect upon the environment and are treated as foreign bodies. Another disadvantage is that they can be sterilized only by means of additions which have a bactericidal effect, but which thereby aggravate the irritation and are furthermore not resorptive. Moreover, previously known materials of this type are very diflicult to apply, and it is impossible accurately to adjust their viscosity, plasticity and other colloidal properties to medical and surgical requirements.
We have discovered certain novel preparations which can be adapted to the above surgical and medical purp'oses with the greatest accuracy and which, furthermore, are entirely free from the disadvantages of other deposit and filling mathe viscosity of the product.
:i Claims. (Cl. 167-58) terials. These novel preparations are polymerized vinyl alcohols of various viscosities, and
their esters, acetals and ethers as well as esteracetals and mixtures of such compounds, in so far as, they have an appreciable solubility in water, which requirement is met in certain cases if the preparations are capable of swelling inwater. These polymerized vinyl compounds are particularly well suited for the above purpose because they do not exercise any irritating effect upon living tissues but are tolerated in any quantity without any reaction; they can be made absolutely sterile without the addition of bactericidal substances because they can stand heating up to 130-140 C. without injury to their properties; and by means of suitable additions, preferably electrolytes and particularly organic acids such as lactic acid, acetic acid and the like, they can be made reabsorbable to any desired degree. Moreover, they are distinguished by an extraordinary compatibility with the most varied medicaments, for instance alkaloids, cardiacs,
gland preparations, et c., anaesthetics, disinfectants, contrast media and cosmetics. Their excellent suitability as vehicles for iodine, iodoform and other iodine preparations is particularly important. In addition, these polymerized vinyl compounds may be treated to form solutions, jellies, pastes or powders adapted merely to swell up with solvents, or kneadable masses, with surprising deftness and with such exactness in their qualities as to meet the requirements of medicine and surgery from the standpoint of the patient as Well as the physician, with the result that the desired final condition is attained with precision and entirely new fields 01' application are made possible.
The foregoing desirable results are obtained by treating the said solutions, jellies, pastes, swollen masses, etc., with solvents such as, for example, glycols, glycerine, formamid, and particularly water, which alter the colloidal properties of these more or less homogeneous mixtures in a manner dictated by thepurposes to which the products are to be applied. The most important characteristic of this change is an alteration of For example it causes more or less free flowing solutions to thicken, gelatinize or become more solid; it causes a further thickening or solidification of jellies; an increase of solidity of pastes; a rigidifying or toughening of plastic masses. In general the purpose is to effect an accurately graded conversion of fiowable materials into thinner or thicker solutions, Jellies and pastes and, finally, into solid, rigid masses with a higher or lower softening point, of lower or higher iusibility; or to render paste-like masses more gelatinous to flowable, or even to liquefy them. This modification may be effected by means of physical or chemical (or colloidal chemical) reactions or a combination of the two. By the action of physical agencies, for instance irradiation, but particularly by means of thermal treatment, the complexion of the colloidal properties of the solutions, pastes, etc., may be changed in the direction which is characterized by an increase of viscosity in the sense indicated above.
If the solutions, pastes, etc., are subjected to the reaction of substances which tend to solidify them, a modification of the colloidal properties in the same direction is effected. Substances which operate to produce a solidifying effect are,
for example, metal compounds such as chromium,
iron and aluminum salts, which have a tanning eflect; also soluble salts of organic acids such as acetates, particularly sodium acetate; and metalloidcompounds which have a tanning effect, such as boric acid and borates, are also effective. A
specific effect in this direction is had by the univalent and polyvalent alcohols, such, for instance, as ethyl alcohol and glycerine; their capacity to absorb water-effects or promotes in a special manner the solidification of the colloids discussed here. Organic dyestuffs of the Congo red and benzo purpurin class as well as other dyestuffs having an equivalent reaction upon colloids are particularly active in this connection.
As a general rule they act in very small concen- 5 By way of example, Congo red is much more efiective than benzo purpurin; accordingly, by using a suitable quantity of benzo purpurin instead of Congo red, in a mass which is non-adhesive and which solidifies at body temperature,
it is possible to obtain a strongly adhesive substance. There are many situations in which this possibility of modification is important: for example in filling cavities in the upper part of the lung it enables us to make the inserted filling adhere strongly to the surface of the cavity so that it will not drop down during breathing; likewise, for segmentary localized lumbar anaesthesia we can produce a deposit material with suitable adhesive capacity together with other so specific properties such as light weight and the capacity to become solid in the body. In other cases it is desirable to make the fillings lie, as far as possible without adhesion in a pocket-like cavity, and fillings for this purpose can also be produced in accordance with our invention.
By meansof appropriate physical or colloidalchemical solidifying methods or combinations of such methods, low concentrated-solutions, jellies, pastes or plastic masses may be given the solidity characteristics of highly concentrated, relatively insoluble substances. In this way, for example, deposits, fillings, etc., which are made solid-for some definite purpose, can be introduced into the body with the incorporation of a disproportionately small quantity of a substance foreign to the body. In certain cases on the other hand, it is desirable to obtain highly concentrated fillings and the like which are as compact as possible, and in such cases concentrated solutions, jellies, pastes or plastic masses may be used and the consistency required for the simplest and best meth- 0d of incorporation into the body may be effected by reducing the viscosity. This may also be accomplished according to our invention by influencing the colloidal propertiesof the mixtures of the above-mentioned polymerized vinyl compounds with solvents, particularly water. For this purpose organic acids, for example lactic acids, tartaric acid, acetic acid and the like may be incorporated in the solutions, pastes, etc. By appropriate selection and proportioning of. the ingredients and suitable treatment of the mixture highly concentrated materials can be introduced into the body in abnormally thin and free flowing condition, these materials only gradually assuming the desired final consistency in the body as a result of the extraction by lixiviation of the lactic acid and the like.
An important advantage of our invention, as illustrated by the examples hereinafter given, is that it enables infusion masses, deposits of medicaments, plastic fillings, stiffening means and the like to be produced with great exactness; it makes it possible to produce materials of this type which can be readily injected into the body at moderate temperatures, for instance 40-44? C. 'in liquid form, and which solidify in the body in accordance with the intended purpose at its temperature range of 36-42 C. and thus localized themselves or permit themselves to be distributed more or less diffused as desired. In this way rib resections, for example in the filling of lung cavities, become unnecessary and are replaced by a simple injection. Our invention also results in a revolutionary improvement in the case of lung operations which heretofore have had to be performed at low or high pressure. As a result of our invention it is no longer necessary in opening the thorax to prevent the dangerous bending over of the mediastinum by artificially influencing pressure relations or conditions, because polymerized vinyl compounds produced according to our invention may be soadjusted that they can be injected into the mediastinum in liquid form and there solidify and thus act as stifi'eners so that bending over during the operation is prevented. This surprisingly advantageous application of these compounds as stifleners in surgical and medical cases is considered to be a particularly valuable feature of the invention.
The following examples are given for the purpose of illustrating the invention without limiting it in any way to the specificconditions, concentrations, etc., which are used: 4
Example 1 A solution of the consistency of honey, composed of 30 parts by weight of medium viscous polymerized vinyl alcohol and parts by weight of water, is converted into a homogeneous jelly by heating for 48 hours to a temperature of 120 C. in a closed glass jar. The resulting product is exceptionally well suited, for example, for filling up cavities in the body or as a joint lubricant. In case reabsorbability is required, it may be effected by the addition of resorption promot ing substances, particularlyorganic acids such as lactic acid or acetic acid.
Example 2 A gum-dry non-homogeneous mixture produced from 60 parts by weight of highly polymerized vinyl alcohol and 90 parts by weight of water is converted by heating for a period of 8 days to 100 C. in a closed bell jar into a homogeneous elastic mass which is gum-like when cold and which becomes soft under heat. This mass also produces good plastic fillings.
Example 3 1000 parts by weight of a readily fiowable aqueous solution of 10% strength of medium viscous polymerized vinyl alcohol are mixed with 2 parts of sodium acetate. This produces a clear, homogeneous, thin jelly, which serves as a plastic filling, a vehicle for deposits of medicaments, and as infusion masses.
Example 4 Example 5 1000 parts by weight of a solution of highly viscous polymerized vinyl alcohol in water, of
6% strength, which is a readily flowable liquid,-
are mixed with 2 parts by weight of Congo red. As a result jellification occurs in the course of a few hours and the point of softening is increased to about 35 C. This mass is suitable as a base for deposits of all kinds and as plastic filling.
Example 6 If the procedure of Example 5 is followed, with the substitution of benzo purpurln for the Congo red, a jelly of lower consistency is obtained.
Example 7 1000 parts by weight of an aqueous solution of highly polymerized vinyl alcohol of 6% strength are hardened, by the addition of 3 parts by weight of benzo purpurin, to a jelly with a jelliflcation point of 27-28 C. a 1
Example 8 If, in carrying out the process ,of Example 7. the benzo purpurin is replaced by the same quantity of Congo red, the viscous solution solidifies to a rigid mass with a solidification point of 42 C. This mass may be liquefied by heating. It maintains this condition on cooling until it can be injected into the body with an injection syringe, for instance as solidification means into the niediastinuni.
Example 9 1000 parts by weight of an aqueous solution of polymerized vinyl alcohol of 7% strength are mixed with 4.2 parts by weight of benzo purpurin. The resulting product is a jelly with a jellification point of 39.5" C., which adheres to serous glands or membranes and other body parts in the form of plastic fillings or deposits for there.-
75 D utically effective substances.
Example 10 If in the process of Example 9 the 4.2 parts by weight of benzo purpurin are replaced by 3.5 parts by weight of Congo red, there is obtained a rigid mass with a solidification point of 43-44 C., which does not adhere to serous glands or membranes or other body parts. It is suited, for example, for plastic fillings which are to rest in a body pocket in a manner capable of moving.
Example 11 A solution of polymerized vinyl alcohol in water, of 8.75% strength, is solidified with the addition of 4.4 parts by weight of Congo red to 1000 parts by weight of said solution, to a mass with a solidification point of 44 C. A quantity of 4 cu. cm. of this mass is mixed, after sterilization by heating to 120 C. for one-half hour, with 1 cu. cm. of sterile hydrochloric acid of 1% normal strength with a common salt content of 7 parts in 1000 parts and 200 guinea pig units of thyreotropic hormone. This mixture has a solidification point of 42-43 C., can be injected into the body upon heating to 44-45 C. by means of a standard injection syringe, and solidifies in the body.
It will be evident that many changes may be made in the processes and products described above without departing from the scope and spirit of the invention as defined in the appended claims.
The invention claimed is: v I
1. A surgical and medical preparation for injection into body cavities in the human and animal system comprising a mixture containing at least one material selected from the group consisting of polymerized vinyl alcohols and their water soluble derivatives, and a solvent for such material, said preparation being capable of being rendered fiowable for ready injection into the body at temperatures above body temperature and which is not injurious to the body and becoming solid at body temperature after injection.
2. A surgical and medical preparation for injection into body cavities in the human and animal system comprising a mixture containing at least one material selected from the group consisting of polymerized vinyl alcohols and their water soluble derivatives, and a solvent for such material, said preparation containing an organic dyestufi' selected from the group consisting of Congo red and benzo purpurin in a quantity sumcient to make said preparation capable of being rendered flowable for ready injection into the body at temperatures above body temperature and which is not injurious to the body and becoming solid at body temperature after inlection.
3. A process of manufacturing surgical and medical preparations for injection into body cavities in the human and animal system comprising mixing at least one material selected from the group consisting of polymerized vinyl alcohols and their water soluble derivatives with a
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US2467583 *||Apr 5, 1946||Apr 19, 1949||Rhone Poulenc Sa||Penicillin solutions|
|US2477292 *||Oct 11, 1946||Jul 26, 1949||Wyeth Corp||Polyvinyl-alcohol-coated suppository|
|US2486937 *||Jul 9, 1947||Nov 1, 1949||Ferguson Jr Edgar A||Digitalis therapy|
|US2693438 *||Feb 21, 1951||Nov 2, 1954||Norwich Pharma Co||Preformed, nonadherent films for application to open lesions|
|US2903396 *||May 8, 1957||Sep 8, 1959||Ciba Pharm Prod Inc||Therapeutic compositions and method for treating parkinsonism|
|US2935472 *||Aug 16, 1954||May 3, 1960||Minnesota Mining & Mfg||Lost circulation materials|
|US3236735 *||Sep 14, 1962||Feb 22, 1966||Mallinckrodt Chemical Works||Barium sulfate and low viscosity monosaccharide polymer x-ray contrast media|
|US3247841 *||May 29, 1961||Apr 26, 1966||Cook Galen B||Diagnostic method|
|US3313292 *||Jun 24, 1965||Apr 11, 1967||Galen B Cook||Diagnostic composition package|
|US3317394 *||Dec 14, 1956||May 2, 1967||Haessle Ab||Medicinal tablet and a method for its preparation|
|US3492250 *||May 21, 1963||Jan 27, 1970||Du Pont||Closed cell foam|
|US3967922 *||Aug 8, 1974||Jul 6, 1976||Bayer Aktiengesellschaft||Granular dyestuff preparations based on polyvinylalcohol as the carrier|
|US4200939 *||Oct 19, 1977||May 6, 1980||Codman & Shurtleff, Inc.||Method for fixation of prostheses to bone|
|US4265875 *||Oct 19, 1979||May 5, 1981||Inveresk Research International||Controlled release suppositories|
|US4292300 *||Jul 20, 1977||Sep 29, 1981||Inveresk Research International||Controlled release suppositories|
|US4296097 *||Feb 27, 1979||Oct 20, 1981||Lee Weng Y||Suppression of reaginic antibodies to drugs employing polyvinyl alcohol as carrier therefor|
|US4302480 *||Jun 15, 1979||Nov 24, 1981||Merck Patent Gesellschaft Mit Beschrankter Haftung||Thin cover sheet for use in microscopic staining and a process for its production|
|US4342745 *||May 19, 1980||Aug 3, 1982||Zyma S.A.||Use of polyvinyl alcohols for the treatment of lesions|
|US4460562 *||Mar 30, 1983||Jul 17, 1984||Key Pharmaceuticals, Inc.||Polymeric diffusion matrix containing propranolol|
|US4466953 *||Sep 30, 1982||Aug 21, 1984||Key Pharmaceuticals, Inc.||Polymeric diffusion matrix|
|US4470962 *||Apr 28, 1981||Sep 11, 1984||Key Pharmaceuticals, Inc.||Polymeric diffusion matrix|
|US4482533 *||Mar 28, 1983||Nov 13, 1984||Key Pharmaceuticals, Inc.||Polymeric diffusion matrix containing propranolol|
|US4492685 *||Jan 30, 1984||Jan 8, 1985||Key Pharmaceuticals, Inc.||Protective skin matrix|
|US5278201 *||Apr 24, 1990||Jan 11, 1994||Atrix Laboratories, Inc.||Biodegradable in-situ forming implants and methods of producing the same|
|US5462990 *||Oct 5, 1993||Oct 31, 1995||Board Of Regents, The University Of Texas System||Multifunctional organic polymers|
|US5487897 *||Sep 28, 1993||Jan 30, 1996||Atrix Laboratories, Inc.||Biodegradable implant precursor|
|US5632727 *||Jun 7, 1995||May 27, 1997||Atrix Laboratories, Inc.||Biodegradable film dressing and method for its formation|
|US5660849 *||Aug 23, 1994||Aug 26, 1997||Atrix Laboratories, Inc.||Apparatus for forming a biodegradable implant precursor|
|US5681873 *||Oct 14, 1993||Oct 28, 1997||Atrix Laboratories, Inc.||Biodegradable polymeric composition|
|US5702716 *||Jun 2, 1993||Dec 30, 1997||Atrix Laboratories, Inc.||Polymeric compositions useful as controlled release implants|
|US5707647 *||Nov 14, 1996||Jan 13, 1998||Atrix Laboratories, Inc.||Adjunctive polymer system for use with medical device|
|US5717030 *||Dec 6, 1996||Feb 10, 1998||Atrix Laboratories, Inc.||Adjunctive polymer system for use with medical device|
|US5722950 *||Jun 7, 1995||Mar 3, 1998||Atrix Laboratories, Inc.||Method for remote delivery of an aerosolized liquid|
|US5733950 *||Sep 25, 1995||Mar 31, 1998||Atrix Laboratories, Incorporated||Biodegradable in-situ forming implants and methods of producing the same|
|US5739176 *||Mar 18, 1994||Apr 14, 1998||Atrix Laboratories, Inc.||Biodegradable in-situ forming implants and methods of producing the same|
|US5744153 *||Jun 9, 1997||Apr 28, 1998||Atrix Laboratories, Inc.||Liquid delivery compositions|
|US5780044 *||Dec 5, 1996||Jul 14, 1998||Atrix Laboratories, Inc.||Liquid delivery compositions|
|US5792469 *||Jun 7, 1995||Aug 11, 1998||Atrix Laboratories, Inc.||Biodegradable in situ forming film dressing|
|US5945115 *||Aug 8, 1997||Aug 31, 1999||Atrix Laboratories, Inc.||Polymeric compositions useful as controlled release implants|
|US5990194 *||Nov 7, 1997||Nov 23, 1999||Atrix Laboratories, Inc.||Biodegradable in-situ forming implants and methods of producing the same|
|US6071530 *||Jun 26, 1997||Jun 6, 2000||Atrix Laboratories, Inc.||Method and composition for treating a bone tissue defect|
|US6083524 *||Oct 6, 1997||Jul 4, 2000||Focal, Inc.||Polymerizable biodegradable polymers including carbonate or dioxanone linkages|
|US6143314 *||Oct 28, 1998||Nov 7, 2000||Atrix Laboratories, Inc.||Controlled release liquid delivery compositions with low initial drug burst|
|US6177095||Jan 7, 2000||Jan 23, 2001||Focal, Inc||Polymerizable biodegradable polymers including carbonate or dioxanone linkages|
|US6395293||Mar 8, 2000||May 28, 2002||Atrix Laboratories||Biodegradable implant precursor|
|US6503894||Aug 30, 2000||Jan 7, 2003||Unimed Pharmaceuticals, Inc.||Pharmaceutical composition and method for treating hypogonadism|
|US7128927||Apr 14, 1998||Oct 31, 2006||Qlt Usa, Inc.||Emulsions for in-situ delivery systems|
|US8226598||Aug 5, 2003||Jul 24, 2012||Tolmar Therapeutics, Inc.||Coupling syringe system and methods for obtaining a mixed composition|
|US8466136||Jul 11, 2011||Jun 18, 2013||Unimed Pharmaceuticals, Llc||Testosterone gel and method of use|
|US8466137||Jul 11, 2011||Jun 18, 2013||Unimed Pharmaceuticals, Llc||Testosterone gel and method of use|
|US8466138||Oct 5, 2011||Jun 18, 2013||Unimed Pharmaceuticals, Llc||Testosterone gel and method of use|
|US8486925||Oct 5, 2011||Jul 16, 2013||Unimed Pharmaceuticals, Llc||Testosterone gel and method of use|
|US8729057||Mar 14, 2013||May 20, 2014||Unimed Pharmaeuticals, LLC||Testosterone gel and method of use|
|US8741881||Mar 14, 2013||Jun 3, 2014||Unimed Pharmaceuticals, Llc||Testosterone gel and method of use|
|US8754070||Mar 14, 2013||Jun 17, 2014||Unimed Pharmaceuticals, Llc||Testosterone gel and method of use|
|US8759329||Mar 14, 2013||Jun 24, 2014||Unimed Pharmaceuticals, Llc||Testosterone gel and method of use|
|US9125816||Aug 13, 2013||Sep 8, 2015||Besins Healthcare Inc.||Pharmaceutical composition and method for treating hypogonadism|
|US9132089||Jul 15, 2013||Sep 15, 2015||Besins Healthcare Inc.||Pharmaceutical composition and method for treating hypogonadism|
|US20040127846 *||Aug 5, 2003||Jul 1, 2004||Dunn Richard L.||Coupling syringe system and methods for obtaining a mixed composition|
|US20040156781 *||Oct 15, 2003||Aug 12, 2004||Porter Christopher H.||Polymeric materials for site specific delivery to the body|
|US20040157953 *||Oct 15, 2003||Aug 12, 2004||Porter Christopher H.||Materials for filling cavities in the body|
|US20040197302 *||Oct 15, 2003||Oct 7, 2004||Porter Christopher H.||Prepolymeric materials for site specific delivery to the body|
|US20050118242 *||Apr 20, 2004||Jun 2, 2005||Dudley Robert E.||Androgen pharmaceutical composition and method for treating depression|
|US20050152956 *||Aug 24, 2004||Jul 14, 2005||Dudley Robert E.||Method of increasing testosterone and related steroid concentrations in women|
|US20070088012 *||Apr 6, 2006||Apr 19, 2007||Woun Seo||Method of treating or preventing type-2 diabetes|
|US20110172196 *||Mar 24, 2011||Jul 14, 2011||Dudley Robert E||Pharmaceutical composition and method for treating hypogonadism|
|US20110201586 *||Mar 24, 2011||Aug 18, 2011||Dudley Robert E||Pharmaceutical composition and method for treating hypogonadism|
|USRE37950||Mar 28, 2000||Dec 31, 2002||Atrix Laboratories||Biogradable in-situ forming implants and methods of producing the same|
|USRE39713||Jan 23, 2003||Jul 3, 2007||Genzyme Corporation||Polymerizable biodegradable polymers including carbonate or dioxanone linkages|
|WO1983000091A1 *||Jul 8, 1982||Jan 20, 1983||Keith, Alec, Dell||Polymeric diffusion matrix containing 5-ad(3,4-dimethoxyphenethyl)methylaminobd-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile|
|WO1983000092A1 *||Jul 8, 1982||Jan 20, 1983||Key Pharma||Polymeric diffusion matrix containing propranolol|
|WO1983000093A1 *||Jul 8, 1982||Jan 20, 1983||Key Pharma||Trinitroglycerol sustained release vehicles and preparation therefrom|
|U.S. Classification||514/772.2, 523/105, 260/DIG.470|
|International Classification||A61K9/00, A61K47/32, A61L27/16|
|Cooperative Classification||A61K9/0019, Y10S260/47, A61K47/32, A61K9/0024, A61L27/16|
|European Classification||A61L27/16, A61K47/32, A61K9/00M5, A61K9/00M5D|